Tag Archives: generic drugs

1 Comment

Jacalyn Duffin is a hematologist and historian who holds the Hannah Chair in the History of Medicine at Queen’s University

 

The sixth full year of the global generic drug shortage has drawn to a close. We Canadians can look back and marvel at how little we still know about the problem. Generic drug shortages do not get anything like the attention paid to the fraught relationship between the federal government and the provinces over a renewed health accord. They are also obscured by concerns over brand-name, on-patent pharmaceuticals, such as the shocking price hikes that occurred overnight last February when Martin Shkreli raised the price of Daraprim from $13.50 to $750, or when Valeant upped the price for a month’s supply of two drugs for Wilson’s disease to more than $25,000. Yet, looking back over 2016, Canada has reported shortages of reliable generic drugs for epilepsy, bladder cancer, psychosis, syphilis, asthma, and kits for treating overdose.  ...continue reading

J_DuffinJacalyn Duffin is a hematologist and historian who holds the Hannah Chair in the History of Medicine at Queen’s University

 

Recently, I addressed first and second year residents in the Queen’s University family medicine program, during their annual retreat at Camp Oconto, near Sharbot Lake, Ontario. Roughly every other year for some time now, I’ve been asked to talk to them about my work on drug shortages and what drives them, my website (which I mentioned in my previous blog), and the mysterious causes, harms and  frustrations of drug shortages. ...continue reading